Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	95177
Country	Poland

Received	2024-04-03 06:40
Peer-Review Started	2024-04-03 06:40
To Make the First Decision
Return for Revision	2024-05-03 04:33
Revised	2024-05-07 08:05
Second Decision	2024-06-04 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-04 06:15
Articles in Press	2024-06-04 06:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-11 13:52
Typeset the Manuscript	2024-06-18 06:55
Publish the Manuscript Online	2024-08-16 15:30

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Treatment strategy and therapy based on immune response in patients with gastric cancers
Manuscript Source	Invited Manuscript
All Author List	Damian Jacenik and Jakub Fichna
Funding Agency and Grant Number
Corresponding Author	Damian Jacenik, Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., Lodz 90-236, Poland. damian.jacenik@biol.uni.lodz.pl
Key Words	Gastric cancer; Metastasis; Immunotherapy; Treatment strategy
Core Tip	Gastric cancer is a highly heterogenous disease which affects patients’ outcomes. Immunotherapy in GC patients seems to provide several clinical benefits and retrospective studies are needed to evaluate immunotherapy efficiency and safety. The aim of this editorial is to provide short and informative introduction elaborating efficiency and safety of immunotherapy in patients with advanced GCs manifested by absence or presence of liver metastasis.
Publish Date	2024-08-16 15:30
Citation	<p>Jacenik D, Fichna J. Treatment strategy and therapy based on immune response in patients with gastric cancers. <i>World J Gastrointest Surg</i> 2024; 16(8): 2393-2395</p>
URL	https://www.wjgnet.com/1948-9366/full/v16/i8/2393.htm
DOI	https://dx.doi.org/10.4240/wjgs.v16.i8.2393

Full Article (PDF)	WJGS-16-2393-with-cover.pdf
Full Article (Word)	WJGS-16-2393.docx
Manuscript File	95177-Review-FilipodiaCL.docx
Answering Reviewers	95177-answering-reviewers.pdf
Audio Core Tip	95177-audio.wav
Conflict-of-Interest Disclosure Form	95177-conflict-of-interest-statement.pdf
Copyright License Agreement	95177-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	95177-non-native-speakers.pdf
Peer-review Report	95177-peer-reviews.pdf
Scientific Misconduct Check	95177-scientific-misconduct-check.png
Scientific Editor Work List	95177-scientific-editor-work-list.pdf
CrossCheck Report	95177-crosscheck-report.pdf
CrossCheck Report	95177-crosscheck-report.png